Standout Papers

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer 2018 2026 2020 2023 341
  1. Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer (2018)
    Tiffany A. Traina, Kathy D. Miller et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 14 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Hirdesh Uppal being referenced

Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
2014

Author Peers

Author Last Decade Papers Cites
Hirdesh Uppal 1015 564 433 33 2.0k
Isabelle Dussault 1355 1011 683 64 2.8k
Anne‐Lise Børresen 1005 1049 166 56 2.3k
Dennis B. Solt 574 1082 219 40 2.3k
John J. Grygiel 489 885 216 48 2.4k
Jyrki J. Eloranta 1125 1110 259 41 2.6k
Harriet Johansson 1023 828 135 81 2.4k
David Jones 807 780 670 57 2.3k
Masanori Miwa 1927 984 140 32 2.9k
Aliana Guerrieri‐Gonzaga 1143 985 146 108 2.5k
Fouad Lafdil 668 635 178 36 2.7k

All Works

Loading papers...

Rankless by CCL
2026